Treatment of Parkinson Disease A 64-Year-Old Man With Motor Complications of Advanced Parkinson Disease

被引:29
|
作者
Tarsy, Daniel [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Parkinson Dis & Movement Disorders Ctr, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Natl Parkinson Fdn Ctr Excellence, Parkinson Dis Ctr, Boston, MA 02215 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 307卷 / 21期
关键词
DEEP-BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; HIGH-FREQUENCY STIMULATION; 5-YEAR FOLLOW-UP; QUALITY-OF-LIFE; GLOBUS-PALLIDUS; THALAMIC-STIMULATION; BILATERAL STIMULATION; COST-EFFECTIVENESS; MEDICAL-TREATMENT;
D O I
10.1001/jama.2012.4829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In early stages, Parkinson disease typically begins with asymmetric or unilateral motor symptoms due to combinations of mild bradykinesia, rigidity, and tremor. In most cases, with progression, signs of more generalized bradykinesia appear, which include facialmasking, reduced voice volume, and slowing of activities of daily living. In more advanced Parkinson disease, other disabling manifestations may follow, such as impaired balance, gait freezing, falls, speech disturbance, and cognitive impairment. Levodopa is the most effective medical treatment for Parkinson disease. However, motor complications uniquely related to levodopa treatment may emerge that may be difficult to manage. These include fluctuating levodopa responses and involuntary movements and postures known as dyskinesia and dystonia. Medication adjustments are usually effective, but in some cases surgical intervention with deep brain stimulation becomes necessary to alleviate motor complications. The case of Mr L, a man with an 11-year history of Parkinson disease, illustrates these emerging motor complications and the manner in which they may be managed both medically and surgically. JAMA. 2012;307(21):2305-2315 www.jama.com
引用
收藏
页码:2305 / 2314
页数:10
相关论文
共 50 条
  • [31] Surgical Treatment of Parkinson's Disease: Devices and Lesion Approaches
    Sharma, Vibhash D.
    Patel, Margi
    Miocinovic, Svjetlana
    NEUROTHERAPEUTICS, 2020, 17 (04) : 1525 - 1538
  • [32] A 64-Year-Old Man With Low-Risk Prostate Cancer Review of Prostate Cancer Treatment
    Sanda, Martin G.
    Kaplan, Irving D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (20): : 2141 - 2151
  • [33] Apomorphine in advanced Parkinson disease
    Bogucki, Andrzej
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2013, 47 (05) : 476 - 483
  • [34] Pharmacoeconomic study of the treatment of advanced Parkinson's disease
    Vivancos-Matellano, Francisco
    Garcia-Ruiz, Antonio J.
    Soler, Nuria Garcia-Agua
    REVISTA DE NEUROLOGIA, 2016, 63 (12) : 529 - 536
  • [35] RECOMMENDATION FOR TREATMENT OPTIONS IN ADVANCED PARKINSON'S DISEASE
    Zsuzsanna, Aschermann
    Gyoergy, Dibo
    Peter, Klivenyi
    Norbert, Kovacs
    Tibor, Kovacs
    Annamaria, Takats
    Gertrud, Tamas
    Lajos, Varannai
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2016, 69 (11-12): : 367 - 372
  • [36] New strategies in the treatment of the advanced Parkinson's disease
    Odin, P
    Mrowka, M
    NERVENHEILKUNDE, 2002, 21 (04) : 174 - 177
  • [37] Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor Complications
    Barbe, Michael T.
    Tonder, Lisa
    Krack, Paul
    Debu, Bettina
    Schupbach, Michael
    Paschen, Steffen
    Dembek, Till A.
    Kuehn, Andrea A.
    Fraix, Valerie
    Brefel-Courbon, Christine
    Wojtecki, Lars
    Maltete, David
    Damier, Phillippe
    Sixel-Doering, Friederike
    Weiss, Daniel
    Pinsker, Marcus
    Witjas, Tatiana
    Thobois, Stephane
    Schade-Brittinger, Carmen
    Rau, Joern
    Houeto, Jean-Luc
    Hartmann, Andreas
    Timmermann, Lars
    Schnitzler, Alfons
    Stoker, Valerie
    Vidailhet, Marie
    Deuschl, Guenther
    Knudsen, K.
    Volkmann, J.
    Falk, D.
    Mehdorn, M.
    Haelbig, T. D.
    Hesekamp, H.
    Navarro, S. M.
    Meier, N.
    Agid, Y.
    Seigneuret, E.
    Kistner, A.
    Chaynes, P.
    Ory-Magne, F.
    Bataille, B.
    Raoul, S.
    Regis, J. -M.
    Mertens, P.
    Helwig, D.
    Oertel, W. H.
    Maarouf, M.
    Fink, G. R.
    Kupsch, A.
    Gruber, D.
    MOVEMENT DISORDERS, 2020, 35 (01) : 82 - 90
  • [38] Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
    Bastide, Matthieu F.
    Meissner, Wassilios G.
    Picconi, Barbara
    Fasano, Stefania
    Fernagut, Pierre-Olivier
    Feyder, Michael
    Francardo, Veronica
    Alcacer, Cristina
    Ding, Yunmin
    Brambilla, Riccardo
    Fisone, Gilberto
    Stoessl, A. Jon
    Bourdenx, Mathieu
    Engeln, Michel
    Navailles, Sylvia
    De Deurwaerdere, Philippe
    Ko, Wai Kin D.
    Simola, Nicola
    Morelli, Micaela
    Groc, Laurent
    Rodriguez, Maria-Cruz
    Gurevich, Eugenia V.
    Quik, Maryka
    Morari, Michele
    Mellone, Manuela
    Gardoni, Fabrizio
    Tronci, Elisabetta
    Guehl, Dominique
    Tison, Francois
    Crossman, Alan R.
    Kang, Un Jung
    Steece-Collier, Kathy
    Fox, Susan
    Carta, Manolo
    Cenci, M. Angela
    Bezard, Erwan
    PROGRESS IN NEUROBIOLOGY, 2015, 132 : 96 - 168
  • [39] Dysfunction of motor cortices in Parkinson's disease
    Chu, Hong-Yuan
    Smith, Yoland
    Lytton, William W.
    Grafton, Scott
    Villalba, Rosa
    Masilamoni, Gunasingh
    Wichmann, Thomas
    CEREBRAL CORTEX, 2024, 34 (07)
  • [40] Prevalence and main methods of treatment of advanced stages of Parkinson's disease
    Seliverstov, Yu. A.
    Illarioshkin, S. N.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (11) : 100 - 106